TransThera Sciences (Nanjing) (2617 HK)

Analysis

Health Care • China

TransThera Sciences (Nanjing), Inc. develops and manufactures biopharmaceutical products. The Company produces oncology, inflammatory, and cardiovascular treatment drugs. TransThera Sciences (Nanjing) serves customers worldwide.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00